RheumaGen: Funding, Investors & Team (Oct 2026)
RheumaGen is a gene-editing technology that is working on developing treatments for curing rheumatoid arthritis. It utilizes an HLA gene-editing platform that utilizes stem-cell-enriched blood to modify DNA in order to suppress the immune system and halt the abnormal immune response associated with rheumatoid arthritis.
RheumaGen has raised $4.9M across 2 funding rounds on record, the most recent a Series A announced in Dec 2025.
RheumaGen Company Profile and Key Stats
Latest funding round on record: Dec 2025.
RheumaGen Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
RheumaGen raised $4.9M in an undisclosed round announced in Apr 2024.
1.7 years later, a Series A was announced in Dec 2025 with no disclosed amount.
RheumaGen Founders and Leadership Team
Contact details for the RheumaGen team: 2 of 2 have an email address on file.
Start 14-day free trial →RheumaGen Funding Compared to Other Biotechnology Startups
Funded Startups Like RheumaGen in Biotechnology and Denver
Companies Similar to RheumaGen
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
RheumaGen Funding FAQs
What does RheumaGen do?
RheumaGen is a gene-editing technology that is working on developing treatments for curing rheumatoid arthritis. It utilizes an HLA gene-editing platform that utilizes stem-cell-enriched blood to modify DNA in order to suppress the immune system and halt the abnormal immune response associated with rheumatoid arthritis.
How much funding has RheumaGen raised?
RheumaGen has raised $4.9M across 2 rounds on record.
When did RheumaGen last raise funding?
RheumaGen's most recent funding round on record was announced in Dec 2025. The amount was not disclosed.
Who founded RheumaGen?
FundedIQ lists Brian Hart (Founder), Richard Freed (Founder) at RheumaGen.
Where is RheumaGen headquartered?
RheumaGen is based in Denver, Colorado, United States.
How many employees does RheumaGen have?
RheumaGen is in the 1-10 employee band.
About FundedIQ's RheumaGen Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for RheumaGen is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.